- Home
- PPBT vs LGCB Comparison
PPBT vs LGCB Comparison
Compare PPBT & LGCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- LGCB
- Stock Information
- Founded
- PPBT 2010
- LGCB 2011
- Country
- PPBT Israel
- LGCB Japan
- Employees
- PPBT N/A
- LGCB N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- LGCB
- Sector
- PPBT Health Care
- LGCB
- Exchange
- PPBT Nasdaq
- LGCB Nasdaq
- Market Cap
- PPBT 6.3M
- LGCB 6.1M
- IPO Year
- PPBT N/A
- LGCB 2023
- Fundamental
- Price
- PPBT $2.62
- LGCB $2.41
- Analyst Decision
- PPBT Strong Buy
- LGCB
- Analyst Count
- PPBT 1
- LGCB 0
- Target Price
- PPBT $33.00
- LGCB N/A
- AVG Volume (30 Days)
- PPBT 30.8K
- LGCB 28.0K
- Earning Date
- PPBT 05-21-2025
- LGCB 06-17-2025
- Dividend Yield
- PPBT N/A
- LGCB N/A
- EPS Growth
- PPBT N/A
- LGCB N/A
- EPS
- PPBT N/A
- LGCB N/A
- Revenue
- PPBT N/A
- LGCB $10,289,681.00
- Revenue This Year
- PPBT N/A
- LGCB N/A
- Revenue Next Year
- PPBT N/A
- LGCB N/A
- P/E Ratio
- PPBT N/A
- LGCB N/A
- Revenue Growth
- PPBT N/A
- LGCB N/A
- 52 Week Low
- PPBT $2.00
- LGCB $1.22
- 52 Week High
- PPBT $13.95
- LGCB $57.05
- Technical
- Relative Strength Index (RSI)
- PPBT 56.64
- LGCB 61.09
- Support Level
- PPBT $2.46
- LGCB $2.17
- Resistance Level
- PPBT $2.80
- LGCB $2.52
- Average True Range (ATR)
- PPBT 0.20
- LGCB 0.17
- MACD
- PPBT 0.04
- LGCB 0.03
- Stochastic Oscillator
- PPBT 66.96
- LGCB 73.46
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.
About LGCB Linkage Global Inc
Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.